Pfizer’s Elranatamab Receives FDA and EMA Filing Acceptance
Go back to Pfizer’s Elranatamab Receives FDA and EMA Filing Acceptance| Pfizer Inc. (NYSE: PFE) | Delayed: 27.05 +0.29 (1.08%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $26.76 | 52 Week High | $37.39 | |||
| Open | $26.58 | 52 Week Low | $28.25 | |||
| Day High | $27.19 | P/E | 16.39 | |||
| Day Low | $26.52 | EPS | $1.65 | |||
| Volume | 52,344,750 | |||||
